Company Aoxing Pharmaceutical Company, Inc. Other OTC
Equities
AOXG
US03740A1060
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2015 | Weight | 2016 | Weight | Delta |
---|---|---|---|---|---|
Narcotics & Pain Management Products
100.0
%
| 25 | 100.0 % | 32 | 100.0 % | +26.88% |
Sales per region
USD in Million | 2015 | Weight | 2016 | Weight | Delta |
---|---|---|---|---|---|
Cnina
100.0
%
| 25 | 100.0 % | 32 | 100.0 % | +26.88% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Duarte
CEO | Chief Executive Officer | - | 11/23/11 |
Gui Rong Zhou
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/11/01 |
Peng Jiang
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Duarte
CEO | Chief Executive Officer | - | 11/23/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 76,209,195 | 76,209,195 ( 100.00 %) | 0 | 100.00 % |
Company contact information
![address Aoxing Pharmaceutical Company, Inc.(AOXG)](https://cdn.zonebourse.com/static/address/38481065.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+21.80% | 4.38TCr | |
+30.40% | 2.3TCr | |
+21.32% | 1.54TCr | |
+19.05% | 1.44TCr | |
+58.92% | 1.3TCr | |
-0.05% | 678.76Cr | |
-11.84% | 649.13Cr | |
-8.87% | 572.55Cr | |
+14.11% | 549.3Cr |